000 01237 a2200313 4500
005 20250515210108.0
264 0 _c20100430
008 201004s 0 0 eng d
022 _a1537-6591
024 7 _a10.1086/650740
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHohmann, Carina
245 0 0 _aRifampin and posaconazole coadministration leads to decreased serum posaconazole concentrations.
_h[electronic resource]
260 _bClinical infectious diseases : an official publication of the Infectious Diseases Society of America
_cMar 2010
300 _a939-40 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAntifungal Agents
_xadministration & dosage
650 0 4 _aDrug Interactions
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aRifampin
_xadministration & dosage
650 0 4 _aSerum
_xchemistry
650 0 4 _aTriazoles
_xadministration & dosage
650 0 4 _aYoung Adult
700 1 _aKang, Elizabeth M
700 1 _aJancel, Timothy
773 0 _tClinical infectious diseases : an official publication of the Infectious Diseases Society of America
_gvol. 50
_gno. 6
_gp. 939-40
856 4 0 _uhttps://doi.org/10.1086/650740
_zAvailable from publisher's website
999 _c19536310
_d19536310